Table 1 Patient characteristics
All | New-onset GCA | Established GCA | |
|---|---|---|---|
Gender | |||
Female | 22 | 5 | 17 |
Male | 13 | 4 | 9 |
Mean age, years | 71 | 72 | 65 |
Disease duration, mean in years | 2.5 (range 0–4) | < 2 months | 2.9 (range 0–8) |
Disease onset | |||
Newly diagnosed | 9 | ||
Established disease | 26 | ||
Visual manifestations | 5 | 0 | 5 |
Jaw claudication | 1 | 1 | 0 |
Arm claudication | 3 | 1 | 2 |
Patients having temporal artery biopsy (TAB) | 23 | 2 | 21 |
TAB positive | 15 | 1 | 14 |
CRP (range) g/L | 7.5 (1–200) | 24 (4–200) | 4 (1–57) |
Corticosteroid dose (range) mg/day | 5 (0–60) | 60 (20–60) | 5 (0–25) |
Steroid sparing medications | |||
Methotrexate | 4 | 0 | 4 |
Leflunomide | 2 | 0 | 2 |
Etanercept | 1 | 0 | 1 |